Literature DB >> 19786595

Atomic force microscopy investigation of the morphology and topography of colistin-heteroresistant Acinetobacter baumannii strains as a function of growth phase and in response to colistin treatment.

Rachel L Soon1, Roger L Nation, Patrick G Hartley, Ian Larson, Jian Li.   

Abstract

The prevalence of infections caused by multidrug-resistant gram-negative Acinetobacter baumannii strains and the lack of novel antibiotics under development are posing a global dilemma, forcing a resurgence of the last-line antibiotic colistin. Our aim was to use atomic force microscopy (AFM) to investigate the morphology and topography of paired colistin-susceptible and -resistant cells from colistin-heteroresistant A. baumannii strains as a function of bacterial growth phase and colistin exposure. An optimal AFM bacterial sample preparation protocol was established and applied to examine three paired strains. Images revealed rod-shaped colistin-susceptible cells (1.65 +/- 0.27 microm by 0.98 +/- 0.07 microm) at mid-logarithmic phase, in contrast to spherical colistin-resistant cells (1.03 +/- 0.09 microm); the latter were also more diverse in appearance and exhibited a rougher surface topography (7.05 +/- 1.3 nm versus 11.4 +/- 2.5 nm for susceptible versus resistant, respectively). Cellular elongation up to approximately 18 microm at stationary phase was more commonly observed in susceptible strains, although these "worm-like" cells were also observed occasionally in the resistant population. The effects of colistin exposure on the cell surface of colistin-susceptible and -resistant cells were found to be similar; topographical changes were minor in response to 0.5 microg/ml colistin; however, at 4 microg/ml colistin, a significant degree of surface disruption was detected. At 32 microg/ml colistin, cellular clumping and surface smoothening were evident. Our study has demonstrated for the first time substantial morphological and topographical differences between colistin-susceptible and -resistant cells from heteroresistant A. baumannii strains. These results contribute to an understanding of colistin action and resistance in regard to this problematic pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786595      PMCID: PMC2786353          DOI: 10.1128/AAC.00497-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Effects of the antimicrobial peptide PGLa on live Escherichia coli.

Authors:  Arnaldo da Silva; Omar Teschke
Journal:  Biochim Biophys Acta       Date:  2003-12-07

2.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Influences of geometrical factors on quantitative surface roughness evaluations by atomic force microscopy.

Authors:  Yuhang Chen; Wenhao Huang
Journal:  J Nanosci Nanotechnol       Date:  2009-02

4.  Centrifugation injury of gram-negative bacteria.

Authors:  P Gilbert; F Coplan; M R Brown
Journal:  J Antimicrob Chemother       Date:  1991-04       Impact factor: 5.790

5.  Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus.

Authors:  Peter Eaton; João C Fernandes; Eulália Pereira; Manuela E Pintado; F Xavier Malcata
Journal:  Ultramicroscopy       Date:  2008-05-07       Impact factor: 2.689

6.  Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime.

Authors:  P C Braga; D Ricci
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

7.  Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection.

Authors:  Y Hirai
Journal:  J Hosp Infect       Date:  1991-11       Impact factor: 3.926

8.  Cell surface analysis techniques: What do cell preparation protocols do to cell surface properties?

Authors:  R S Pembrey; K C Marshall; R P Schneider
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

9.  AFM study of the effect of metronidazole on surface structures of sulfate-reducing bacteria.

Authors:  Z Y Chen; X P Guo; J Y Huang; Y L Hong; Q Zhang
Journal:  Anaerobe       Date:  2006-02-03       Impact factor: 3.331

10.  Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology.

Authors:  Andrew P Tomaras; Michael J Flagler; Caleb W Dorsey; Jennifer A Gaddy; Luis A Actis
Journal:  Microbiology       Date:  2008-11       Impact factor: 2.777

View more
  20 in total

1.  Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.

Authors:  N C Gordon; K Png; D W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  Qualitative and Quantitative Changes to Escherichia coli during Treatment with Magainin 2 Observed in Native Conditions by Atomic Force Microscopy.

Authors:  Kanesha Overton; Helen M Greer; Megan A Ferguson; Eileen M Spain; Donald E Elmore; Megan E Núñez; Catherine B Volle
Journal:  Langmuir       Date:  2020-01-08       Impact factor: 3.882

3.  Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Authors:  Alejandro Beceiro; Enrique Llobet; Jesús Aranda; José Antonio Bengoechea; Michel Doumith; Michael Hornsey; Hiran Dhanji; Henrik Chart; Germán Bou; David M Livermore; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 4.  Atomic Force Microscopy: A Promising Tool for Deciphering the Pathogenic Mechanisms of Fungi in Cystic Fibrosis.

Authors:  Stéphane Cuenot; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2017-11-11       Impact factor: 2.574

5.  Klebsiella pneumoniae antibiotic resistance identified by atomic force microscopy.

Authors:  Vincenzo Ierardi; Paolo Domenichini; Silvia Reali; Gian Marco Chiappara; Gianluigi Devoto; Ugo Valbusa
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

6.  Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.

Authors:  Rachel L Soon; Roger L Nation; Marina Harper; Ben Adler; John D Boyce; Chun-Hong Tan; Jian Li; Ian Larson
Journal:  Int J Antimicrob Agents       Date:  2011-09-16       Impact factor: 5.283

Review 7.  Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.

Authors:  Lauren M Lim; Neang Ly; Dana Anderson; Jenny C Yang; Laurie Macander; Anthony Jarkowski; Alan Forrest; Jurgen B Bulitta; Brian T Tsuji
Journal:  Pharmacotherapy       Date:  2010-12       Impact factor: 4.705

8.  Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.

Authors:  Rachel L Soon; Roger L Nation; Stewart Cockram; Jennifer H Moffatt; Marina Harper; Ben Adler; John D Boyce; Ian Larson; Jian Li
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

9.  An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.

Authors:  Alberto Oddo; Thomas T Thomsen; Susanne Kjelstrup; Ciara Gorey; Henrik Franzyk; Niels Frimodt-Møller; Anders Løbner-Olesen; Paul R Hansen
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

10.  Cell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implications.

Authors:  R L Soon; J Li; J D Boyce; M Harper; B Adler; I Larson; R L Nation
Journal:  J Appl Microbiol       Date:  2012-10       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.